VDAC Antibodies

Santa Cruz Biotechnology features a diverse variety of VDAC monoclonal antibodies for investigating voltage-dependent anion channels (VDAC) in cellular processes. VDAC monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VDAC proteins regulate the transport of metabolites and ions across the mitochondrial membrane, playing a vital role in cellular energy metabolism and apoptosis. The involvement of VDAC in mitochondrial function makes it particularly relevant for studies related to cancer, neurodegenerative diseases, and metabolic disorders. Research focused on VDAC can reveal potential therapeutic targets for various diseases. Scientists worldwide rely on VDAC monoclonal antibodies to advance their understanding of mitochondrial biology. Investigating VDAC function contributes to breakthroughs in cellular metabolism research. Current studies utilizing VDAC monoclonal antibodies continue to reveal new insights into disease mechanisms and potential treatments. Santa Cruz Biotechnology monoclonal antibodies support researchers in expanding scientific knowledge of mitochondrial biology and its impact on human health.